Congratulations to PI, Stephen Meyn, MD, PhD, and Co-Investigator Christopher Bradfield, PhD (UW Oncology), on funding of their project, “A critical tool for human genomics and precision medicine: De novo human genome assembly.” This one-year project pairs the Center for Human Genomics and Precision Medicine and the UW Biotechnology Center in making now affordable and reliable ultra-long read-based de novo human genome assembly widely available to UW researchers and clinicians so that they can reach these missing regions of the human genome and untangle complex genomic rearrangements in normal tissues and tumors. This resource will put the UW-Madison at the cutting edge of genome science, drive disease gene discovery, and gain novel insights into cancer biology, as well as identify new therapeutic targets for cancer therapy. This project is one of 12 to be funded in the 6th round of the UW2020: WARF Discovery Initiative, and has been awarded funding of $157,381 from UW’s Office of the Vice Chancellor for Research and Graduate Education and the Wisconsin Alumni Research Foundation. See link for additional information: https://research.wisc.edu/a-critical-tool-for-human-genomics-and-precision-medicine-de-novo-human-genome-assembly/